Beyond KRAS mutation status: influence of KRAScopy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients

被引：0
|
作者：
Leonie JM Mekenkamp
Jolien Tol
Jeroen R Dijkstra
Inge de Krijger
M Elisa Vink-Börger
Shannon van Vliet
Steven Teerenstra
Eveline Kamping
Eugène Verwiel
Miriam Koopman
Gerrit A Meijer
J Han JM van Krieken
Roland Kuiper
Cornelis JA Punt
Iris D Nagtegaal
机构：
[1] Radboud University Nijmegen Medical Centre,Department of Medical Oncology
[2] Radboud University Nijmegen Medical Centre,Department of Pathology
[3] Radboud University Nijmegen Medical Centre,Department of Epidemiology, Biostatistics and Health Technology Assessment
[4] Radboud University Nijmegen Medical Centre,Department of Human Genetics
[5] University Medical Center Utrecht,Department of Medical Oncology
[6] VU University Medical Center,Department of Pathology
[7] University of Amsterdam,Department of Medical Oncology, Academic Medical Centre
来源：
BMC Cancer | / 12卷
关键词：
Cetuximab; KRAS Mutation; Copy Number Change; Poor Responder; Copy Number Gain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status
    Lukan, Nadine
    Stroebel, Philipp
    Willer, Andreas
    Kripp, Melanie
    Dinter, Dietmar
    Mai, Sabine
    Hochhaus, Andreas
    Hofheinz, Ralf-Dieter
    ONCOLOGY, 2009, 77 (05) : 293 - 299
  • [32] SUVmax and metabolic tumor volume: surrogate image biomarkers of KRAS mutation status in colorectal cancer
    Lv, Ying
    Wang, Xin
    Liang, Lerong
    Wang, Lei
    Lu, Jie
    ONCOTARGETS AND THERAPY, 2019, 12 : 2115 - 2121
  • [33] Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome
    Jesús García-Foncillas
    Eduardo Díaz-Rubio
    Clinical and Translational Oncology, 2010, 12 : 533 - 542
  • [34] Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
    Chen, Yu
    Shi, Yi
    Lin, Jing
    Ye, Yun-bin
    Wang, Xiao-jie
    Chen, Gang
    Guo, Zeng-qing
    MEDICINE, 2015, 94 (40)
  • [35] Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer
    Nakamoto, Kentaro
    Nagahara, Hisashi
    Maeda, Kiyoshi
    Noda, Eiji
    Inoue, Toru
    Yashiro, Masakazu
    Nishiguchi, Yukio
    Ohira, Masaichi
    Hirakawa, Kosei
    ONCOLOGY LETTERS, 2013, 5 (04) : 1295 - 1300
  • [36] KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications
    Antoine Italiano
    Isabelle Hostein
    Isabelle Soubeyran
    Thibault Fabas
    Daniel Benchimol
    Serge Evrard
    Jean Gugenheim
    Yves Becouarn
    René Brunet
    Marianne Fonck
    Eric François
    Marie-Christine Saint-Paul
    Florence Pedeutour
    Annals of Surgical Oncology, 2010, 17 : 1429 - 1434
  • [37] First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study
    Sastre, Javier
    Gravalos, Cristina
    Rivera, Fernando
    Massuti, Bartomeu
    Valladares-Ayerbes, Manuel
    Marcuello, Eugenio
    Manzano, Jose L.
    Benavides, Manuel
    Hidalgo, Manuel
    Diaz-Rubio, Eduardo
    Aranda, Enrique
    ONCOLOGIST, 2012, 17 (03) : 339 - 345
  • [38] Impact of mutational status of KRAS in the care of patients with colorectal cancer metastasis
    Assenat, E.
    Ychou, M.
    BULLETIN DU CANCER, 2009, 96 : S41 - S46
  • [39] Metastatic Profile of Colorectal Cancer: Interplay Between Primary Tumor Location and KRAS Status
    Yong, Zachary Zihui
    Ching, Grace Tan Hwei
    Ching, Melissa Teo Ching
    JOURNAL OF SURGICAL RESEARCH, 2020, 246 : 325 - 334
  • [40] CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach
    Taguchi, Narumi
    Oda, Seitaro
    Yokota, Yasuhiro
    Yamamura, Sadahiro
    Imuta, Masanori
    Tsuchigame, Tadatoshi
    Nagayama, Yasunori
    Kidoh, Masafumi
    Nakaura, Takeshi
    Shiraishi, Shinya
    Funama, Yoshinori
    Shinriki, Satoru
    Miyamoto, Yuji
    Baba, Hideo
    Yamashita, Yasuyuki
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 118 : 38 - 43
12345